US 9775881
Methods of treating mesothelioma by administration of compounds comprising FGFR1 ECD
granted A61KA61K31/337A61K31/519
Quick answer
US patent 9775881 (Methods of treating mesothelioma by administration of compounds comprising FGFR1 ECD) held by Five Prime Therapeutics, Inc. expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/337, A61K31/519, A61K31/555, A61K33/243